CD3

CD3 is a multi-subunit protein complex found on the surface of all T lymphocytes, associated non-covalently with the T-cell receptor (TCR) to form the TCR-CD3 complex. The CD3 complex consists of four distinct chains (γ, δ, ε, and ζ) that contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic tails. While the TCR itself recognizes peptide-MHC complexes, it lacks significant intracellular signaling capacity; CD3 chains transduce the activation signal into the cell upon TCR engagement, triggering downstream signaling cascades (e.g., Lck, ZAP-70 activation, phospholipase C-γ, and eventually NFAT, NF-κB, and AP-1 transcription factor activation) that lead to T-cell activation, proliferation, and cytokine production. Because CD3 is expressed on all T cells (both CD4+ and CD8+) but not on B cells or NK cells, it serves as a reliable pan-T-cell marker in flow cytometry and immunohistochemistry, useful in diagnosing T-cell lymphomas/leukemias and characterizing immunodeficiencies. Clinically, CD3 is also the target of muromonab-CD3 (OKT3), an anti-CD3 monoclonal antibody historically used for treatment of acute transplant rejection (largely replaced by newer agents due to cytokine release syndrome risk). Genetic defects in CD3 chains (e.g., CD3δ or CD3ε deficiency) can cause severe combined immunodeficiency (SCID)-like syndromes due to impaired T-cell development and signaling. Understanding CD3 is important for grasping T-cell receptor signaling, immunodeficiency syndromes, and the mechanism of certain immunosuppressive therapies.